-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
There is no definitive treatment of severe COVID-19 drug
COVID-19 immunity
The study included severely hospitalized patients in the early lung stage of COVID-19 diagnosed in Iran.
From April 20, 2020 to June 20, 2020, 68 eligible patients received randomized treatment (34 patients in each group)
In summary, the results of the study show that methylprednisolone pulse can be an effective treatment for hospitalized patients with severe COVID-19 in the lung stage
Original source:
Maryam Edalatifard, Maryam Akhtari, et al.
Intravenous methylprednisolone pulse as a treatment for hospitalised severe COVID-19 patients: results from a randomised controlled clinical trial
in this message